Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer

AIMS: Pelvic lymph node (PLN) radiotherapy for high-risk prostate cancer is limited by late gastrointestinal toxicity. Application of rectal and bowel constraints may reduce risks of side-effects. We evaluated associations between intensity-modulated radiotherapy (IMRT) dose-volume data and long-ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, M.R., Thomas, K., Truelove, L., Khan, A., Parker, C., Dearnaley, D.P., Gulliford, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505687/
https://www.ncbi.nlm.nih.gov/pubmed/30902559
http://dx.doi.org/10.1016/j.clon.2019.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505687/
https://www.ncbi.nlm.nih.gov/pubmed/30902559
http://dx.doi.org/10.1016/j.clon.2019.02.012

Ejemplares similares